NOVARTIS AG (NVSEF)
Clinical trial NCT06824103: primary completion date: 2029-11-29 → 2029-05-10.
Clinical trial NCT06824103: primary completion date: 2029-11-29 → 2029-05-10.
Clinical trial NCT07566052 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2026-04-30 → 2026-04-28
Clinical trial NCT07228117 updates: 1. completion date: 2027-02-01 → 2027-01-01 2. primary completion date: 2027-02-01 → 2027-01-01
Clinical trial NCT07489287: status: NOT_YET_RECRUITING → RECRUITING.
Clinical trial NCT03681561: primary completion date: 2026-03-01 → 2026-09-01.
Clinical trial NCT07586202: start date: 2026-07-28 → 2026-07-17.
Clinical trial NCT04924075 updates: 1. completion date: 2029-06-04 → 2029-12-27 2. primary completion date: 2029-06-04 → 2029-12-27 3. enrollment: 322 → 355 participants
Clinical trial NCT05271409 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. completion date: 2028-12-31 → 2028-05-20
Clinical trial NCT06712654 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2026-05-31 → 2026-06-01
Clinical trial NCT06975787 updates: 1. completion date: 2028-07-23 → 2029-09-09 2. primary completion date: 2028-07-23 → 2029-09-09